We are aware some users might find it difficult to log into our site today. We are working on this issue and hope to have it resolved shortly.
Research and commentary

The benefits of newborn screening to identify cystic fibrosis early on

Since its roll-out in the UK in 2007, newborn screening programmes to identify cystic fibrosis have proven to help provide growth developments in later life

Rueegg CS, Barben J, Hafen GM et al (2016) Newborn screening for cystic fibrosis – The parent perspective. Journal of Cystic Fibrosis. 15, 4, 443-451.


Newborn screening (NBS) identifies pre-symptomatic babies that are either at risk of carrying or are affected by genetic or congenital conditions (UK Newborn Screening Programme Centre 2012). Screening for cystic fibrosis (CF) is not diagnostic and further testing is required once a positive screening result has been obtained to determine whether the child is affected by CF.

NBS programmes for CF have not been introduced universally worldwide, with some countries


Want to read more?

Unlock full access to RCNi Plus today

Save over 50% on your first three months:

  • Customisable clinical dashboard featuring 200+ topics
  • Unlimited online access to all 10 RCNi Journals including Nursing Children and Young People
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • NMC-compliant RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests

This article is not available as part of an institutional subscription. Why is this?